Featured News
A melanoma clinical trial with a site in Carlton, Victoria, will examine the effectiveness of Melanoma Surveillance Photography – offering state-of-the-art technology aiming to improve surveillance for people at high risk of melanoma.
A world-wide clinical trial is now hoping to resolve this issue by investigating whether there is a difference in disease-free survival for patients treated with either a 1cm or 2cm excision margin for stage II primary cutaneous melanoma.
New melanoma research has shown the concurrent use of two drugs that slow the growth of metastatic melanoma, Dabrafenib and Trametinib, are safe to use during palliative radiation therapy.
A drug commonly used to treat prostate and breast cancer is being trialled in Bendigo to determine its effectiveness in treating melanoma, and more Bendigo residents with melanoma are being sought for the study.
A new melanoma clinical trial involving Bass Coast residents aims to improve surveillance for people at high risk of melanoma.
The AOMA-funded virtual ocular melanoma nurse is a new specialist telehealth service to support patients with ocular melanoma in remote and regional areas of Australia.
Professor H. Peter Soyer is focused on improving the early detection of skin cancer through a nationwide melanoma screening program.
Over the last 30 years, Paul has had almost 30 moles removed from his body. His scars tell the story of life-saving, but invasive, surgeries. Through his work with MASC Trials, Paul advocates for melanoma and skin cancer patients, as well as new diagnostic and treatment options.
Over the last 30 years, Paul has had almost 30 moles removed from his body. His scars tell the story of life-saving, but invasive, surgeries. Through his work with MASC Trials, Paul advocates for melanoma and skin cancer patients, as well as new diagnostic and treatment options.
When Diagnosed with stage 4 metastatic melanoma, part-owner of champion racehorse Black Caviar, Gary Wilkie made a split-second decision that he’s forever thankful for.